A Look Ahead Toward Possible Future Analytical Requirements by FDA

  • Daniel Banes
Part of the Progress in Analytical Chemistry book series (PAC)


Even the most venturesome clairvoyants, with their heads in the clouds and their gaze fixed on futurity, must stand firmly on the ground of the present; and therefore they generally open their dark parable on the shape of things to come with a recitation depicting the status of things as they are, as accurately as circumstances permit. In that tradition, I take as my point of departure a brief exposition on the current analytical requirements of FDA before embarking on my personal prognostication foreshadowing the lineaments toward which future requirements might evolve. Please note at the outset my emphasis on the first person singular, and the disclaimer such usage implies. The prophecies I offer on this program are my own, and do not necessarily adumbrate the developing attitudes and actions of the sponsor.


Electron Spin Resonance Analytical Requirement Ethinyl Estradiol Content Uniformity Cortisone Acetate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Plenum Press, New York 1973

Authors and Affiliations

  • Daniel Banes
    • 1
  1. 1.Office of Pharmaceutical Research and TestingBureau of Drugs Food and Drug AdministrationUSA

Personalised recommendations